Medical Information Only. Consult your healthcare provider before enrolling in any clinical trial.
North Dakota: below-average open trial sites
44 of 235 in-state trials are recruiting (19%); below the 37% national average by 18 percentage points.
According to ClinicalTrials.gov-derived indexes, North Dakota sits in the lower half of US states by in-state trial count (#49 of 52 states by registered in-state trial count).
North Dakota: 235 US clinical trials with in-state sites, 44 recruiting.
North Dakota has 235 registered US clinical trials with a study site in-state, 44 of them currently recruiting (below the 37% national average by 18 percentage points). 49 of these trials are in Phase 3 (late-stage) and 51 in Phase 2. The most frequently studied condition in North Dakota is Healthy, with 30 linked trials.
Thin-volume North Dakota archive
North Dakota open-enrollment share is 19% (p0 of states with sites; national baseline 37%). Treat this page as a compact local index (thin-volume · low-open), then jump to recruiting trials or methodology rather than expecting hub-scale coverage.
Below-average open enrollment
North Dakota still shows 44 recruiting of 235 in-state trials (19% open), but below the 37% national average by 18 percentage points, so archived statuses weigh heavier than the national baseline.
- 19%
- open (below national share)
- 44
- still recruiting despite cool share
- 51
- Phase 2 rows in this footprint
- 30
- top: Healthy
Recruiting share is below the 37% national average by 18 percentage points. Counts include every study with at least one recorded site in the state. Registry reference only, not medical advice.
North Dakota vs all states by indexed in-state trial count
Where this state's ClinicalTrials.gov site count sits among every state with at least one listed trial (coverage density, not care quality)
235 Top 94% more indexed trials than 6% of 52 states
States, banded by indexed in-state trial count
Each bar is a band; taller bars hold more states. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov · 2026-08-08
Key findings
What ClinicalTrials.gov does not surface for North Dakota on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
North Dakota open-enrollment share sits below the national baseline.
44 of 235 in-state trials (18.7%) are recruiting, against 37% nationally (-18.3 percentage points). Counts include every study with at least one recorded site in the state.
-
Fargo dominates North Dakota's trial geography.
Fargo lists 185 of 235 in-state trials (78.7%) across 87 named facilities. Cities need five or more listed trials to appear here; locations are as filed by sponsors.
-
Healthy is the most-studied condition in North Dakota.
30 of 235 in-state trials (12.8%) list Healthy. That is a local concentration figure, not a national disease ranking.
-
North Dakota sponsorship is fragmented across many organizations.
Alliance for Clinical Trials in Oncology appears on 18 of 235 in-state trials (7.7%). Sponsor identity is as filed on ClinicalTrials.gov.
-
Most North Dakota indexed trials have already finished enrollment.
157 of 235 (66.8%) are completed. The open share above is the remainder that still lists recruiting.
By Status
| Status | Trial count |
|---|---|
| Completed | 157 |
| Recruiting | 44 |
| Active | 34 |
By Phase
| Phase | Trial count |
|---|---|
| Phase 1 | 55 |
| Phase 2 | 51 |
| Phase 3 | 49 |
| NA | 42 |
| Phase 4 | 9 |
| Early Phase 1 | 2 |
Top Conditions
Top Sponsors
Where trials run in North Dakota
Fargo carries 185 of North Dakota's 235 indexed trials (79%) across 87 named sites, ahead of Bismarck at 39. 5 cities clear five listed trials, together naming 132 distinct sites.
| City | Trials | Listed sites |
|---|---|---|
| Fargo | 185 | 87 |
| Bismarck | 39 | 25 |
| Grand Forks | 31 | 10 |
| West Fargo | 7 | 5 |
| Minot | 5 | 5 |
Distinct trials and named sites per city, as filed with ClinicalTrials.gov; cities under five trials omitted. Vintage 2026-08-08.
Open-share low
North Dakota open-enrollment share is 19% (p0 of states with sites; national baseline 37%).
North Dakota: open share sits in the low tercile of states
Geography is concentrated: Fargo alone accounts for 79% of North Dakota's indexed trials (185 of 235), with Bismarck a distant second at 39.
Phase mix: 49 Phase 3 vs 51 Phase 2 (balanced across stages).
Top condition: Healthy (30 trials); top sponsor Alliance for Clinical Trials in Oncology (18).
thin-volume · low-open figures (235 trials · 19% open) describe registry geography under the open-share low read, not clinic capacity or protocol fit. Confirm status on ClinicalTrials.gov before acting.
States near North Dakota on open-enrollment share
Cross-state peers under the open-share low read (thin-volume · low-open), not the same-state browse list.
Similar thin-volume peers (± open share)
- South Dakota · 273 trials · 31% recruiting
- West Virginia · 277 trials · 36% recruiting
- Vermont · 191 trials · 31% recruiting
- Wyoming · 17 trials · 35% recruiting
- Puerto Rico · 14 trials · 57% recruiting